Welcome to the Neueder lab!

We are interested in neurodegenerative diseases.
We are interested in RNA biology.
We use a combination of molecular and systems biology approaches
to gain insights into disease mechanism.


THE PEOPLE
Meet the people in the lab.
research
THE RESEARCH
Discover our research projects and learn about the methods we use. See our publications and funding bodies.
CONTACT
Address, directions and other contact details.
lab
LAB NEWS
Read news from the lab.


current and former lab members

Christoph Janiesch (Technical assistant)
Julia Natan (MSc, 2022)
Mirjam Skobowsky (BSc, 2022)
Leonard Saitta (Dr. med., 2021)
Ronja Wagner (BSc, 2021)
Alshaimaa Abdelmoez (postdoc, 2019 - 2024)
Franziska Hoschek (Dr. rer. nat., 2019 - 2023)
Nousheen Iram-Muehlinghaus (postdoc, 2020 - 2021)
Judith Rammoser (Dr. med., 2019 - 2020)
Julia Hummel (Dr. med., 2019 - 2020)
Philipp Nitzschner (Dr. med., 2019 - 2020)
Franziska Hoschek (MSc, 2019)

Nathalie Birth (Technical assistant)


Open positions

If you are intersted in our work and would like to be part of the team, please contact us.

HD_triade

Huntington's Disease (HD)

(A) The CAG repeat expansion mutation in HTT leads to a polyQ tract in the HTT protein. (B) HD manifests with a triade of motor (chorea), cognitive and psychiatric symptoms.

Huntington disease (HD) was first described in 1872 by George Huntington and is a late-onset, autosomal dominant, inherited neurodegenerative disorder. It is caused by a CAG repeat expansion mutation in exon 1 of the HTT gene resulting in an expanded polyglutamine (polyQ) tract in the huntingtin protein.
Read more
here

The expanded polyQ tract of mutated HTT results in toxic gains-of-function of the protein, the generation of small fragments of HTT, the appearance of aggregates and disruption of various cellular processes. Eventually these events lead to cell death, most prominent in the neurons of the striatum.
Read more
here

We have previously identified a novel mechanism that leads to the generation of the most toxic fragment of HTT: exon 1 HTT. This fragment consists only of exon 1 of the HTT gene including the polyQ tract. The generation of this fragment is based on a block in the correct splicing reaction of exon 1 HTT to exon 2 HTT resulting in the generation of a novel small RNA HTT1a. This RNA based pathogenic process occurs in all knock-in mouse models of HD, and most importantly also in human HD patients.
Read the publications
here



The Projects

We use a combination of molecular biology and systems biology approaches to unravel mechanisms driving HD pathogenesis.
Generation of novel models
We design, establish and analyse new models for certain aspects of pathogenetic mechanisms in HD.
'omics
We generate and analyse 'big data' in the context of HD. These datasets come from various biological sources and we use state-of-the-art technologies and bioinformatics to evaluate and integrate the 'omics datasets.
RNA biology
We are interested in the contribution of RNA-based mechanisms to cell (type specific) toxicity in HD. In particular we try to unravel mechanisms that contribute to the incomplete splicing of the HTT mRNA.
Extracellular Vesicles
EV biology is disturbed in HD. Our findings offer new insights into HD biology and molecular mechanisms contributing to disease progression, as well as the use of EVs as attractive biomarkers in the context of clinical trials.
splicing

Collaborations

ZMNH, D    Kneussel lab    read more
UKE, D    Braunger lab    read more

UCL, UK    Bates lab    read more

UCL, UK    Tabrizi lab   read more

Ulm, D    Landwehrmeyer lab    read more

LNCA, F    Merienne lab   read more


Find us


News - 2024


BIG News!

We have moved to Hamburg at the Center for Molecular Neurobiology (ZMNH).
Exciting future research awaits!

Come and visit us here or contact us if want further information.

Extracellular Vesciles in HD

In the present study, we demonstrate that examining extracellular vesicles (EVs) can give new insights into pathologic mechanisms in Huntington disease.EVs from HD individuals convey specific actionable information in comparison to EVs from healthy people highlighting the biological relevance and potential use of EVs as a biomarker in clinical trials.
https://doi.org/10.1002/ctm2.1525

Pathogenic mt-DNA mutations accumulate in HD

We show that life-long expression of mutant HTT causes a mitochondrial phenotype indicative of mtDNA instability in fresh post-mitotic human skeletal muscle. Thus, genomic instability may not be limited to nuclear DNA.
https://doi.org/10.1093/brain/awae007

News - 2023


News - 2022


MTM-HD

The MTM-HD study, a multi-omics analysis of HD patient peripheral tissues has been accepted by Genome Biology! We show abnormal molecular signatures of inflammation, energy metabolism and vesicle biology.
https://doi.org/10.1186/s13059-022-02752-5

TGFβ signaling in the Retina

TGFβ signaling in retinal neurons and Müller cells exhibits a neuroprotective effect and might pose promising therapeutic options to attenuate photoreceptor degeneration in humans.
https://doi.org/10.3390/ijms23052626

MTM-HD preprint

Read our pre-print about the MTM-HD study, a multi-omics analysis of HD patient peripheral tissues. We show abnormal molecular signatures of inflammation, energy metabolism and vesicle biology.
https://doi.org/10.1101/2022.02.03.475821

News - 2021


The nucleolus in HD

The integrity of the nucleolus is an important contributor to the formation of HTT aggregates. Monitoring this could prove to be a biomarker for HD progression.
https://doi.org/10.1038/s41419-021-04432-x

Retinitis pigmentosa

We have analysed the transcriptional changes in a model for retinits pigmentosa, a neurodegenerative disease of the retina.
https://doi.org/10.3390/ijms22126307

Habilitation

Dr. Neueder successfully finished his Habilitation in the field of experimental neurology at Ulm University.

News - 2020


BW-HDZ teaching certificate

Dr. Neueder successfully finished his BW-HDZ 'Baden-Württemberg-Zertifikat für Hochschuldidaktik'.
Read about it here.

News - 2019


Junior faculty

Dr. Neueder became a member of the International Graduate School in Molecular Medicine Ulm (IGradU) junior faculty.
Read about it here.

Paper got Published

Our paper showing that phenotype onset in Huntington’s disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene is published in the Journal of Neuroscience Research. Read it here: https://doi.org/10.1002/jnr.24493

News - 2018


website created

Website is running